SS
State Street Corp disclosed a 5.1% stake in CYTK
State Street Corp reported owning 5.1% of Cytokinetics Inc (CYTK) (7,143,229 shares) in a Schedule 13G filed Nov 10, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
Cookies show us what works. Privacy
Cookies show us what works. Privacy
State Street Corp reported owning 5.1% of Cytokinetics Inc (CYTK) (7,143,229 shares) in a Schedule 13G filed Nov 10, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.